PCM
MED icon

Palouse Capital Management’s Medifast MED Stock Holding History

Palouse Capital Management’s Portfolio MED Stock Details MED Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		– Sell
-2,497
Closed -$274K – 87
2019
Q4 		$274K Sell
2,497
-587
-19% -$56.8K 0.1% 66
2019
Q3 		$320K Buy
+3,084
New +$331K 0.12% 69
2014
Q2 		– Sell
-10,460
Closed -$304K – 122
2014
Q1 		$304K Sell
10,460
-750
-7% -$20.1K 0.11% 104
2013
Q4 		$293K Sell
11,210
-15
-0.1% -$384 0.11% 106
2013
Q3 		$302K Sell
11,225
-75
-0.7% -$2.01K 0.12% 101
2013
Q2 		$291K Buy
+11,300
New +$297K 0.12% 94

Other funds holding MED

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
EC
Engaged Capital Newport Beach, California $327M AUM 22.96% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
MVP
Miller Value Partners Sarasota, Florida $423M AUM 49.14% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
RHJA
Rice Hall James & Associates San Diego, California $2.05B AUM 43.16% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $3.01B AUM 119.46% 1-Year Est. Return

Palouse Capital Management's MED Position: Q1 2020 in Review

Palouse Capital Management sold out of Medifast (MED) in Q1 2020, closing a stake of 2,497 shares — an estimated $274K sold.

Palouse Capital Management first reported a position in MED in Q2 2013 and held it in 6 quarters. The position peaked at $320K in Q3 2019. 201 funds tracked by Wall St. Rank hold MED as of Q1 2020.

  • Palouse Capital Management reported no remaining Medifast position as of Q1 2020 after selling out during the quarter.
  • Palouse Capital Management sold 2,497 Medifast shares in Q1 2020, an estimated $274K.
  • Palouse Capital Management first reported a position in Medifast in Q2 2013 and held it in 6 quarters.
  • Palouse Capital Management's Medifast position peaked at $320K in Q3 2019.
  • 201 funds tracked by Wall St. Rank held Medifast as of Q1 2020.

Based on Palouse Capital Management's 13F filing for Q1 2020, filed 7 May 2020.